Quantcast
Last updated on April 17, 2014 at 12:33 EDT

Latest meniere's disease Stories

2013-12-11 08:29:57

- FDA grants Fast Track designation for OTO-104 - SAN DIEGO, Dec. 11, 2013 /PRNewswire/ -- Otonomy, Inc., a clinical stage biopharmaceutical company developing innovative therapeutics for diseases and disorders of the inner and middle ear, today announced enrollment of the first patient in its pivotal Phase 2b study of OTO-104 for the reduction of vertigo in patients with unilateral Meniere's disease. The company also announced that the U.S. Food and Drug Administration (FDA)...

2013-12-09 10:01:39

Researchers at University of Colorado School of Medicine may have figured out what causes Meniere's disease and how to attack it. According to Carol Foster, MD, from the department of otolaryngology and Robert Breeze, MD, a neurosurgeon, there is a strong association between Meniere's disease and conditions involving temporary low blood flow in the brain such as migraine headaches. Meniere's affects approximately 3 to 5 million people in the United States. It is a disabling disorder...

2012-06-17 23:01:21

Meniere's Disease & Trigeminal Neuralgia Breakthrough; A Story of Survival! Learn about important traditional & complementary alternatives to one-sided neurological problems like Meniere's Disease, Trigeminal Neuralgia, Glossopharyngeal Neuralgia, Bell's Palsy, Parkinson's Disease & Migraines. Grand Rapids, MI (PRWEB) June 17, 2012 The featured speaker at this years Meniere's Disease Research Institute's Work Shop is Dr. Michael T. Burcon, world's leading expert on Meniere's...

2012-03-19 23:01:53

The first national treatment guideline for sudden hearing loss, a frightening condition that sends thousands in the U.S. to the emergency room each year, was published this month in the journal Otolaryngology—Head and Neck Surgery. The guideline was developed by a 19-member panel led by Robert J. Stachler, M.D., an otolaryngologist in the Department of Otolaryngology-Head & Neck Surgery at Henry Ford Hospital in Detroit. Detroit, Michigan (PRWEB) March 19, 2012 The first national...

2012-03-19 17:01:08

The first national treatment guideline for sudden hearing loss, a frightening condition that sends thousands in the U.S. to the emergency room each year, was published this month in the journal Otolaryngology—Head and Neck Surgery. The guideline was developed by a 19-member panel led by Robert J. Stachler, M.D., an otolaryngologist in the Department of Otolaryngology-Head & Neck Surgery at Henry Ford Hospital in Detroit. "In most cases, patients will have multiple visits with...

2011-10-25 16:37:00

ROCKVILLE, Md., Oct. 25, 2011 /PRNewswire/ -- The Metropolitan NeuroEar Group and the Balance Center of Maryland are pleased to announce the launch of their patient education website, Earsite.com (http://www.earsite.com/). Dr. Sanjay Prasad, founder, noted that "the website continues our mission of providing the ultimate in patient care by educating our patients about their disorder so that they can make the best decisions regarding their care." The content-rich, interactive website...

2011-09-29 06:30:00

SAN DIEGO, Calif., Sept. 29, 2011 /PRNewswire/ -- Otonomy, Inc., a clinical stage biopharmaceutical company developing innovative therapeutics for diseases and disorders of the inner and middle ear, today announced that researchers presented positive new data from a Phase 1b study of the company's lead product candidate, OTO-104, in patients with Meniere's disease. The presented data showed that patients treated with OTO-104 experienced clinically meaningful reductions in vertigo...

2011-05-25 06:30:00

SAN DIEGO, May 25, 2011 /PRNewswire/ -- Otonomy, Inc., a clinical stage biopharmaceutical company developing innovative therapeutics for diseases and disorders of the inner and middle ear, today announced the appointment of Gerald Wroblewski as the company's chief operations officer. Mr. Wroblewski brings the company broad operational expertise in the areas of manufacturing, product supply chain management, packaging and quality assurance. At Otonomy, he will be responsible for...

2011-04-28 06:30:00

SAN DIEGO, April 28, 2011 /PRNewswire/ -- Otonomy, Inc., a clinical stage biopharmaceutical company developing innovative therapeutics for diseases and disorders of the inner and middle ear, today announced positive data from a Phase 1b study of the company's lead product candidate, OTO-104, in patients with Meniere's disease. Study results showed OTO-104 to be well-tolerated at both doses tested when delivered via a single intratympanic (IT) injection. Additionally, while not powered...

2010-11-02 00:00:39

Ten years of Meniere's disease research by Dr. Michael T. Burcon results in eliminaion of vertigo in 291 out of 300 patients. Grand Rapids, MI (PRWEB) November 1, 2010 Michael T. Burcon, DC started researching Meniere's disease (MD) ten years ago after having three MD patients quickly recover from their vertigo under upper cervical specific chiropractic care. His papers have been published in the Journal of Vertebral Subluxation Research and the textbook, Upper Cervical Subluxation Complex,...